About Thomas Meier, Ph.D., M.D.
Form D filings for Visgenx in 2023 list Thomas Meier, Ph.D., M.D. as director.
Thomas Meier, Ph.D., M.D. first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Meier, Ph.D., M.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Meier, Ph.D., M.D. works with at each company, as listed on that company's latest Form D.
Visgenx, Inc. · Form D, Jun 14, 2023
MD
Martin Emanuele, Ph.D.
Executive officer and director
ED
Elaine Heron, Ph.D.
Director
WP
William Pedranti
Chief Executive Officer and director
AB
Arthur Becker
Director
SD
Santosh Vetticaden, Ph.D., M.D.
Director
ED
Eric Carter, Ph.D., M.D.
Director